Cargando…
Tocilizumab: Active tuberculosis following off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532512/ http://dx.doi.org/10.1007/s40278-021-04457-x |
Ejemplares similares
-
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021) -
Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021) -
Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020) -
Tocilizumab: Anastomotic leakage following off label use: case report
Publicado: (2021) -
Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021)